Anticentromere antibody positive Sjögren's Syndrome: a retrospective descriptive analysis

• Published in: Arthritis research & therapy 2010-01, Vol.12 (2), p.R47-R47, Article R47
• Main Authors: Bournia, Vasiliki-Kalliopi K, Diamanti, Konstantina D, Vlachoyiannopoulos, Panayiotis G, Moutsopoulos, Haralampos M
• Format: Article
• Language: English
• Subjects: Adult; Antibodies; Autoantibodies - blood; Centromere - immunology; Centromeres; Deglutition Disorders - complications; Deglutition Disorders - immunology; Development and progression; Diagnosis; Female; Humans; Keratoconjunctivitis Sicca - blood; Keratoconjunctivitis Sicca - complications; Keratoconjunctivitis Sicca - immunology; Male; Middle Aged; Properties; Raynaud Disease - complications; Raynaud Disease - immunology; Research article; Retrospective Studies; Rheumatoid arthritis; Scleroderma, Systemic - blood; Scleroderma, Systemic - complications; Scleroderma, Systemic - immunology; Sclerosis; Sjogren's Syndrome - blood; Sjogren's Syndrome - complications; Sjogren's Syndrome - immunology; Viral antibodies
• ISSN: 1478-6354; 1478-6362; 1478-6354
• DOI: 10.1186/ar2958

A subgroup of patients with primary Sjögren's Syndrome (SS) and positive anticentromere antibodies (ACA) were recognized as having features intermediate between SS and systemic sclerosis (SSc). Our goal was to describe this group clinically and serologically and define its tendency to evolve to full blown SSc. Among 535 patients with primary SS we identified 20 ACA positive (ACA+/SS). We compared them to 61 randomly selected ACA negative SS patients (ACA-/SS), 31 ACA positive SSc patients with sicca manifestations [SSc/(+) sicca] and 20 ACA positive SSc patients without sicca manifestations [SSc/(-) sicca]. Prevalence of ACA among SS patients was 3.7%. Cases and controls did not differ in sex ratio and age at disease onset. ACA+/SS patients had a lower prevalence of dry eyes, hypergammaglobulinaemia, anti-Ro and anti-La antibodies and a higher prevalence of Raynaud's phenomenon and dysphagia compared to ACA-/SS patients. They also had lower prevalence of telangiectasias, puffy fingers, sclerodactyly, Raynaud's phenomenon, digital ulcers and gastroesophageal reflux in comparison to both of the SSc subgroups and a lower prevalence of dyspnoea and lung fibrosis compared to the SSc/(+) sicca subgroup. Two patients originally having ACA+/SS evolved to full blown SSc. Four deaths occurred, all among SSc patients. Kaplan Meier analysis showed a significant difference between cases and controls in time from disease onset to development of gastroesophageal reflux, telangiectasias, digital ulcers, arthritis, puffy fingers, xerostomia, hypergammaglobulinaemia and dysphagia. ACA+/SS has a clinical phenotype intermediate between ACA-/SS and SSc and shows little tendency to evolve to SSc.